OraQ announced the official launch of its commercial operations in North America, offering dentists a state-of-the-art clinical decision support system that harnesses the analytical power of artificial intelligence and machine learning.
“We are so excited to launch OraQ’s technology to dentists everywhere, giving them software that drives precision patient care and has been shown to increase treatment acceptance rates by up to 30%,” said CEO and co-founder, Dr. Amreesh Khanna.
Unlike other artificial intelligence platforms available today, OraQ’s FDA and Health Canada approved platform is far more than just an imaging tool.
According to co-founder Dr. Mike Parchewsky, “OraQ is a comprehensive treatment planning technology that analyzes the complete patient profile to uncover treatment opportunities that might otherwise be missed.”
“After years of working with disparate dental data, we have harnessed the power of AI to provide useful insights to clinicians and patients,” said co-founder and chief technical officer, Wayne Madhlangobe.
With its interactive patient portal, dentists are finding improved patient engagement through enhanced trust and transparency. The result is a better experience for both patient and clinician.
“Our impact and vision are about helping Dentists every day and anywhere deliver a patient experience that will be fulfilling and create lasting and meaningful relationships with their patients,” said Dr. Khanna.
For more information, visit www.OraQ.ai.
